Scientific Presentations

Explore Orexo’s recent clinical data and R&D breakthroughs. Our scientific posters and presentations demonstrate how Orexo is transforming drug delivery—providing stable, fast-acting powder formulations for critical treatments.

Scientific Presentation

Epinephrine Nasal Powder – A Sustainable and Reliable Option for the Treatment of Anaphylaxis

This work investigated stability of the powder formulation in comparison to a commercial autoinjector.

Scientific Presentation

Spray Dried Amorphous Epinephrine Nasal Powder for the Acute Treatment of Anaphylaxis

We have developed a rapidly dissolving, spray-dried, nasal powder formulation that addresses the stability challenges of liquid forms while preserving the advantages of nasal administration.

Scientific Presentation

Bioavailability and Stability of Epinephrine Nasal Powder Formulations for Treatment of Anaphylaxis

With prompt administration, epinephrine is an effective life-saving treatment of anaphylactic shock. 

Scientific Presentation

Amorphous Powder for Nasal Delivery: Intranasal Naloxone Powder for Treating Opioid Overdose

Intranasal Naloxone Powder for Treating Opioid Overdose.

Meet Orexo at the following scientific conferences

Dec. 9-11 Drug Delivery to the Lungs Conference 2026, Edinburgh, Scotland

Conference link

Nov. 12-16, 2026 ACAAI, American College of Allergy, Asthma & Immunology's Annual Scientific Meeting, Phoenix, Arizona

Conference link

Nov. 9-11, 2026 Bio-Europe 2026, Cologne, Germany

Conference link

Oct. 29-30, 2026 PODD 2026, Boston, MA

Conference link

Oct. 19 -21, 2026 World vaccine conference 2026, Amsterdam, Netherlands

Conference link

Sep. 16 -17, 2026 IPAC-RS 2026 Nasal Innovation Forum

Conference link